Wealth Alliance Advisory Group’s Journey Medical DERM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-10,748
Closed -$16.9K 174
2023
Q1
$16.9K Sell
10,748
-5,376
-33% -$10K 0.01% 163
2022
Q4
$31K Sell
16,124
-5,376
-25% -$10.6K 0.01% 167
2022
Q3
$53K Buy
+21,500
New +$73.3K 0.02% 153

Other funds holding DERM

Wealth Alliance Advisory Group's DERM Position: Q2 2023 in Review

Wealth Alliance Advisory Group sold out of Journey Medical (DERM) in Q2 2023, closing a stake of 10,748 shares — an estimated $16.9K sold.

Wealth Alliance Advisory Group first reported a position in DERM in Q3 2022 and held it in 3 quarters. The position peaked at $53K in Q3 2022. 20 funds tracked by Wall St. Rank hold DERM as of Q2 2023.

  • Wealth Alliance Advisory Group reported no remaining Journey Medical position as of Q2 2023 after selling out during the quarter.
  • Wealth Alliance Advisory Group sold 10,748 Journey Medical shares in Q2 2023, an estimated $16.9K.
  • Wealth Alliance Advisory Group first reported a position in Journey Medical in Q3 2022 and held it in 3 quarters.
  • Wealth Alliance Advisory Group's Journey Medical position peaked at $53K in Q3 2022.
  • 20 funds tracked by Wall St. Rank held Journey Medical as of Q2 2023.

Based on Wealth Alliance Advisory Group's 13F filing for Q2 2023, filed 13 Jul 2023.